368 related articles for article (PubMed ID: 12826840)
1. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses.
Kasper SM; Meinert P; Kampe S; Görg C; Geisen C; Mehlhorn U; Diefenbach C
Anesthesiology; 2003 Jul; 99(1):42-7. PubMed ID: 12826840
[TBL] [Abstract][Full Text] [Related]
2. Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin.
Vogt NH; Bothner U; Lerch G; Lindner KH; Georgieff M
Anesth Analg; 1996 Aug; 83(2):262-8. PubMed ID: 8694303
[TBL] [Abstract][Full Text] [Related]
3. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
[TBL] [Abstract][Full Text] [Related]
4. Volume replacement therapy during hip arthroplasty using hydroxyethyl starch (130/0.4) compared to lactated Ringer decreases allogeneic blood transfusion and postoperative infection.
Hamaji A; Hajjar L; Caiero M; Almeida J; Nakamura RE; Osawa EA; Fukushima J; Galas FR; Auler JO
Braz J Anesthesiol; 2013 Jan; 63(1):27-35. PubMed ID: 24565088
[TBL] [Abstract][Full Text] [Related]
5. Failure of autologous fresh frozen plasma to reduce blood loss and transfusion requirements in coronary artery bypass surgery.
Kasper SM; Giesecke T; Limpers P; Sabatowski R; Mehlhorn U; Diefenbach C
Anesthesiology; 2001 Jul; 95(1):81-6; discussion 6A. PubMed ID: 11465588
[TBL] [Abstract][Full Text] [Related]
6. Avoidance of blood transfusion in coronary artery surgery: a trial of hydroxyethyl starch.
Belcher P; Lennox SC
Ann Thorac Surg; 1984 May; 37(5):365-70. PubMed ID: 6201145
[TBL] [Abstract][Full Text] [Related]
7. Effect of hydroxyethyl starch 130/0.4 on blood loss and coagulation in patients with recent exposure to dual antiplatelet therapy undergoing off-pump coronary artery bypass graft surgery.
Lee JS; Ahn SW; Song JW; Shim JK; Yoo KJ; Kwak YL
Circ J; 2011; 75(10):2397-402. PubMed ID: 21817820
[TBL] [Abstract][Full Text] [Related]
8. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery.
Gallandat Huet RC; Siemons AW; Baus D; van Rooyen-Butijn WT; Haagenaars JA; van Oeveren W; Bepperling F
Can J Anaesth; 2000 Dec; 47(12):1207-15. PubMed ID: 11132743
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs.
Van der Linden PJ; De Hert SG; Deraedt D; Cromheecke S; De Decker K; Paep R; Rodrigus I; Daper A; Trenchant A
Anesth Analg; 2005 Sep; 101(3):629-634. PubMed ID: 16115963
[TBL] [Abstract][Full Text] [Related]
10. Blood transfusion, colloid therapy and the possible saving of albumin volumes during surgery: data analysis of the survey for certified hospitals of the Japanese Society of Anesthesiologists.
Miyao H;
J Anesth; 2016 Jun; 30(3):384-90. PubMed ID: 26768898
[TBL] [Abstract][Full Text] [Related]
11. Infusion of 7.2% NaCl/6% hydroxyethyl starch 200/0.5 in on-pump coronary artery bypass surgery patients: a randomized, single-blind pilot study.
Lomivorotov VV; Fominskiy EV; Efremov SM; Nepomniashchikh VA; Lomivorotov VN; Chernyavskiy AM; Shilova AN; Karaskov AM
Shock; 2014 Mar; 41(3):193-9. PubMed ID: 24549094
[TBL] [Abstract][Full Text] [Related]
12. Immune and inflammatory role of hydroxyethyl starch 130/0.4 and fluid gelatin in patients undergoing coronary surgery.
Öztürk T; Onur E; Cerrahoğlu M; Çalgan M; Nizamoglu F; Çivi M
Cytokine; 2015 Jul; 74(1):69-75. PubMed ID: 25458745
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
Schramko A; Suojaranta-Ylinen R; Kuitunen A; Raivio P; Kukkonen S; Niemi T
Br J Anaesth; 2010 Jun; 104(6):691-7. PubMed ID: 20388624
[TBL] [Abstract][Full Text] [Related]
14. Volume replacement therapy during hip arthroplasty using hydroxyethyl starch (130/0.4) compared to lactated Ringer decreases allogeneic blood transfusion and postoperative infection.
Hamaji A; Hajjar L; Caiero M; Almeida J; Nakamura RE; Osawa EA; Fukushima J; Galas FR; Auler Junior JO
Braz J Anesthesiol; 2013; 63(1):27-35. PubMed ID: 23438799
[TBL] [Abstract][Full Text] [Related]
15. Six percent hydroxyethyl starch 130/0.4 (Voluven®) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients.
Van der Linden P; De Villé A; Hofer A; Heschl M; Gombotz H
Anesthesiology; 2013 Dec; 119(6):1296-309. PubMed ID: 23934169
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a waxy maize and a potato starch-based balanced hydroxyethyl starch for priming in patients undergoing coronary artery bypass grafting.
Sethi BS; Chauhan S; Bisoi AK; Kapoor PM; Kiran U; Rajput RS
J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):690-7. PubMed ID: 24144628
[TBL] [Abstract][Full Text] [Related]
17. A randomized, controlled study of fluid management in infants and toddlers during surgery: hydroxyethyl starch 6% (HES 70/0.5) vs lactated Ringer's solution.
Paul M; Dueck M; Joachim Herrmann H; Holzki J
Paediatr Anaesth; 2003 Sep; 13(7):603-8. PubMed ID: 12950861
[TBL] [Abstract][Full Text] [Related]
18. Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution.
Ickx BE; Bepperling F; Melot C; Schulman C; Van der Linden PJ
Br J Anaesth; 2003 Aug; 91(2):196-202. PubMed ID: 12878617
[TBL] [Abstract][Full Text] [Related]
19. Effects of 6% hydroxyethyl starch 130/0.4 on postoperative blood loss and kidney injury in off-pump coronary arterial bypass grafting: A retrospective study.
Min JJ; Cho HS; Jeon S; Lee JH; Lee JJ; Lee YT
Medicine (Baltimore); 2017 May; 96(18):e6801. PubMed ID: 28471979
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac surgery.
Skhirtladze K; Base EM; Lassnigg A; Kaider A; Linke S; Dworschak M; Hiesmayr MJ
Br J Anaesth; 2014 Feb; 112(2):255-64. PubMed ID: 24169821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
